Financial Performance - Second quarter sales were $870.0 million, down 0.8% year over year, but up 0.9% in constant currency[1] - GAAP EPS for the second quarter was $0.79, a decrease of 2.2% compared to 2024, while adjusted EPS was $0.83, an increase of 2.5%[1] - Operating income margin decreased to 14.4%, down 40 basis points year over year, while adjusted operating margin increased to 15.2%[7][6] - Full-year adjusted EPS guidance is narrowed to between $3.60 and $3.68, with sales forecasted to be flat to up 4% compared to the prior year[9][10] - Net earnings for the six months ended January 31, 2025, were $194.9 million, up from $190.8 million in the same period of 2024, representing a growth of 1.6%[23] - The company reported net earnings of $95.9 million for the three months ended January 31, 2025, compared to $98.7 million in the same period last year[38] - Adjusted diluted EPS for the three months ended January 31, 2025, was $0.83, up from $0.81 in the prior year[39] - The adjusted EBITDA for the six months ended January 31, 2025, was $327.3 million, an increase from $311.9 million in the prior year[38] Segment Performance - The company generated sales growth in Aftermarket (up 4.0%), Aerospace and Defense (up 18.7%), and Life Sciences (up 9.2%) segments[3][5] - Mobile Solutions segment sales decreased 0.5%, with Off-Road and On-Road sales declining 12.8% and 24.4%, respectively[4] - Industrial Solutions segment sales decreased 3.7%, primarily due to volume declines, while Aerospace and Defense sales grew 18.7%[5] - The Mobile Solutions segment reported net sales of $870.0 million for the three months ended January 31, 2025, down 0.8% from $876.7 million in the same period of 2024[28] - The Industrial Solutions segment saw a 3.7% decrease in net sales to $253.7 million for the three months ended January 31, 2025, compared to $263.4 million in 2024[28] - Life Sciences segment net sales increased by 9.2% to $68.8 million for the three months ended January 31, 2025, compared to $63.0 million in 2024[28] - The Life Sciences segment showed a strong performance with a 12.8% increase in revenue for the six months ended January 31, 2025, driven by a 24.2% growth in the U.S./CA region[32] - The Aerospace and Defense sector within the Industrial Solutions segment experienced a significant revenue increase of 22.6% for the six months ended January 31, 2025[32] - The Aftermarket segment in Mobile Solutions saw a revenue increase of 7.3% for the six months ended January 31, 2025, with a 9.3% growth in the U.S./CA region[32] - The total revenue for the Industrial Solutions segment remained flat with a slight increase of 0.3% for the six months ended January 31, 2025[32] - The On-Road category in Mobile Solutions faced a decline of 19.5% for the six months ended January 31, 2025, particularly impacted in the U.S./CA region[32] Cash Flow and Investments - Capital expenditures are forecasted to be between $85 million and $100 million, with free cash flow conversion expected between 85% and 95%[13] - Free cash flow for the three months ended January 31, 2025, was reported at $71.5 million, compared to $65.8 million in the same period last year[38] - The cash conversion ratio improved to 74.4% for the three months ended January 31, 2025, compared to 66.7% in the same period of 2024[25] - The company anticipates repurchasing 2% to 3% of its outstanding shares during the fiscal year[13] Tax and Liabilities - The effective tax rate for the company was 23.2%, compared to 23.5% in the previous year[8] - The effective tax rate for the six months ended January 31, 2025, was 23.7%, down from 24.2% in the same period of 2024[25] - Total current liabilities decreased slightly to $765.8 million from $782.5 million, a reduction of 2.5%[21] Assets and Overall Growth - Total assets increased to $2,961.3 million as of January 31, 2025, compared to $2,914.3 million on July 31, 2024, reflecting a growth of 1.6%[21] - Total company revenue increased by 2.7% for the six months ended January 31, 2025, with a notable growth of 5.6% in the U.S./CA region[32]
Donaldson(DCI) - 2025 Q2 - Quarterly Results